Private Equity Fund - $10 Million Pharmaceutical Revenue Acquisition
2003
Representation of one of the leading purchasers of private equity in the secondary market in connection with a $10 million acquisition of interests in revenues generated by pharmaceutical products. (Prior firm experience)
2003
Representation of one of the leading purchasers of private equity in the secondary market in connection with a $10 million acquisition of interests in revenues generated by pharmaceutical products. (Prior firm experience)
 |
 |
 |
 |
Copyright 2013, Herrick, Feinstein LLP. All Rights Reserved. An ICVM Group Site